MX9203438A - Metodo para inhibir el crecimiento de celulas progenitoras. - Google Patents

Metodo para inhibir el crecimiento de celulas progenitoras.

Info

Publication number
MX9203438A
MX9203438A MX9203438A MX9203438A MX9203438A MX 9203438 A MX9203438 A MX 9203438A MX 9203438 A MX9203438 A MX 9203438A MX 9203438 A MX9203438 A MX 9203438A MX 9203438 A MX9203438 A MX 9203438A
Authority
MX
Mexico
Prior art keywords
inhibiting
growth
cells
progenital
agents
Prior art date
Application number
MX9203438A
Other languages
English (en)
Inventor
Ian B Pragnell
Debra D Donaldson
Gerald J Graham
Gordon G Wong
Original Assignee
Genetics Inst
Crc Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27021719&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203438(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genetics Inst, Crc Technology Ltd filed Critical Genetics Inst
Publication of MX9203438A publication Critical patent/MX9203438A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
MX9203438A 1989-09-25 1992-06-26 Metodo para inhibir el crecimiento de celulas progenitoras. MX9203438A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41230389A 1989-09-25 1989-09-25
US58171390A 1990-09-13 1990-09-13

Publications (1)

Publication Number Publication Date
MX9203438A true MX9203438A (es) 1992-07-01

Family

ID=27021719

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203438A MX9203438A (es) 1989-09-25 1992-06-26 Metodo para inhibir el crecimiento de celulas progenitoras.

Country Status (10)

Country Link
US (1) US5674841A (es)
EP (1) EP0494268B2 (es)
JP (1) JPH05502443A (es)
AT (1) ATE124421T1 (es)
CA (1) CA2064558C (es)
DE (1) DE69020573T3 (es)
DK (1) DK0494268T4 (es)
ES (1) ES2076378T5 (es)
MX (1) MX9203438A (es)
WO (1) WO1991004274A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69130981D1 (de) * 1990-09-14 1999-04-15 Chiron Corp Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
AU679436B2 (en) * 1991-12-23 1997-07-03 British Bio-Technology Limited Stem cell inhibiting proteins
FR2691153B1 (fr) * 1992-05-18 1995-06-30 Serbio Dodecapeptides monomere et dimere, utilisation en tant qu'agents anti-megacaryocytaires.
WO1994022915A1 (en) * 1993-03-31 1994-10-13 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
GB9308060D0 (en) * 1993-04-19 1993-06-02 Cancer Res Campaign Tech Stem cell inhibitor
ES2172536T3 (es) * 1993-06-15 2002-10-01 British Biotech Pharm Liberacion y movilizacion de celulas hematopoyeticas.
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US6623942B2 (en) 1994-03-08 2003-09-23 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polynucleotides
EP0696639B1 (en) * 1994-08-13 2002-04-17 Boehringer Mannheim Gmbh Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells
DE69526395D1 (de) * 1994-08-13 2002-05-23 Roche Diagnostics Gmbh Verwendung von Interferon-gamma zur Vermeidung der Proliferation und Differenzierung der primitiven Hämapoietischen Vorläuferzellen
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US5981230A (en) * 1994-08-23 1999-11-09 Human Genome Sciences, Inc. Polynucleotide encoding chemokine β-4
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
US6040431A (en) * 1995-06-07 2000-03-21 Stryker Corporation Single chain analogs of the TGF-β superfamily (morphons)
ZA97990B (en) * 1996-02-09 1997-08-06 Schering Corp Mammalian dendritic cell chemokine reagents.
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
NZ332318A (en) * 1996-03-19 2000-10-27 Human Genome Sciences Inc Chemokine alpha 2 and it's therapeutic and diagnostic use in treating illnesses
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
US6946445B1 (en) 1998-03-13 2005-09-20 The University Of British Columbia Therapeutic chemokine receptor antagonists
US7097832B1 (en) 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
AU767402B2 (en) * 1999-03-30 2003-11-06 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
CA2335109A1 (en) * 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Cxcr4 agonist treatment of hematopoietic cells
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー 胚性細胞の定方向分化
EP1534752B1 (en) 2002-05-01 2011-08-03 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US8921315B1 (en) * 2008-04-24 2014-12-30 Neumedicines, Inc. Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12
MX361929B (es) 2010-11-19 2018-12-19 Eisai R&D Man Co Ltd Star Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822776A (en) * 1981-09-08 1989-04-18 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
DE3852918T2 (de) * 1987-09-28 1995-07-13 Beecham Inc TGEV-Virus vom Schwein als Impfstoff für Hunde.
US5041289A (en) * 1987-11-13 1991-08-20 Becton Dickinson And Company Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
EP0763543A2 (en) * 1988-09-02 1997-03-19 The Rockefeller University A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody
WO1991000103A1 (en) * 1989-06-29 1991-01-10 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1

Also Published As

Publication number Publication date
US5674841A (en) 1997-10-07
CA2064558A1 (en) 1991-03-26
WO1991004274A1 (en) 1991-04-04
DK0494268T3 (da) 1995-08-28
EP0494268B1 (en) 1995-06-28
ES2076378T5 (es) 1999-10-16
CA2064558C (en) 2001-01-30
DE69020573D1 (de) 1995-08-03
DK0494268T4 (da) 1999-11-08
EP0494268A1 (en) 1992-07-15
ES2076378T3 (es) 1995-11-01
ATE124421T1 (de) 1995-07-15
DE69020573T3 (de) 1999-12-16
DE69020573T2 (de) 1995-11-30
JPH05502443A (ja) 1993-04-28
EP0494268B2 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
MX9203438A (es) Metodo para inhibir el crecimiento de celulas progenitoras.
MX9206577A (es) COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
ES2058799T3 (es) Composiciones estabilizadas que contienen factor de crecimiento epidermico.
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
ES275579Y (es) Juego de celdas para el crecimiento de plantas
IL60614A0 (en) Method and compositions containing heterocyclic compounds for combating fungus and/or regulating plant growth,certain novel heterocyclic compounds and their preparation
AR217878A1 (es) Composicion para regular el crecimiento de plantas leguminosas,que contienen acidos 3-aril-4-isotiazolcarboxilicos o acidos 3-aril-4-isoxazolcarboxilicos
UA39171C2 (uk) Насіння рослин, спосіб захисту насіння від грибкових захворювань і фунгіцидна композиція для захисту насіння від грибкових захворювань
BR9102321A (pt) Composicao,metodo de estabilizar um material organico,composto
ES8407321A1 (es) "un procedimiento para preparar un compuesto organico de selenio"
MXPA99009874A (es) Nuevos derivados de amidina.
NO890996D0 (no) Fremgangsmaate for fremstilling av cefemforbindelser.
ES8800171A1 (es) Procedimiento de obtencion de nuevos derivados nitrogenados penta o hexa ciclicos sustituidos por un radical aminado
JPS533519A (en) Preventives for viral blight of plant
IT8023631A0 (it) Derivati di nitroalcanol,procedimento per produrli e composizioni di protezione per piante che li contengono.
BR7808242A (pt) Composto,processo para regulacao do crescimento de plantas leguminosas,e composicao reguladora do crescimento de plantas
BR8901834A (pt) Composicao reguladora do crescimento de plantas,processos para regulacao e inibicao do crescimento e aplicacao
IT8322439A0 (it) Derivati di 28-metil-brassinosteroidi, procedimento per la preparazione di questi composti e mezzi che licontengono con effetto regolatore della crescita per piante.
DK159847C (da) Salte af 5-cyanopyridin-2-diazohydroxid
ATE56583T1 (de) Pflanzenschutzzusammensetzung.
JPS5378248A (en) Method of preventing yellowing of polyolefin composition
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
IT7822120A0 (it) Derivati della 1, 2,3-tiadiazolin-2-ide, procedimento per la preparazione di questi composti nonche' mezzi che licontengono con azione regolatrice della crescita per piante.
DK162072C (da) Farmaceutisk middel indeholdende en pyrazindiazohydroxidforbindelse til haemning af vaekst af celler
IT8223502A0 (it) Derivati della 1,2,3-tiadiazol-5-il-urea, procedimento per preparare questi composti nonche' mezzi con effetto regolatore della crescita e defogliante che li contengono.